2015 American Transplant Congress

May 2-6, 2015 in Philadelphia, Pennsylvania

View by Title View Sessions

View by Date

Jump to: View All • a b c d e f g h i j k l m n [o] p q r s t u v w x y z

Obesity: A Major Risk Factor for Wound and Parietal Complications in Renal Transplantation

H. Andrade, W. Nahas, R. Kato, K. Yamaçake, H. Kanashiro, I. Antonopoulos, A. Bull, R. Falci, A. Piovesan.
Octogenarian Kidney Transplant Recipients: A Single Center Experience

B. Ravichandran, T. Sparkes, B. Thomas, F. Rasetto, M. Gillespie, M. Moss, S. Bartlett, B. Masters.
Once Daily Dosing Is as Effective as Twice Daily Dosing of Immediate Release Tacrolimus

L. Bowman,¹ T. Horwedel,¹ J. Hagopian,¹ B. Bone,² H. Wijeweera,² D. Brennan.²
Once-a-Day Administration of CNIs, mTOR and MMF Is Safe in De Novo Renal Transplant Recipients: 1-Year Results of a Pilot Study

G. Spagnoletti, M. Salerno, E. Favi, J. Pedroso, J. Romagnoli, F. Citterio.
One Year Outcomes and Quality of Life Measurements in 127 Extended Criteria Donor Recipients- A Single Centre Comparative Study

Y. Tabbakh,¹ S. Turner,¹ H. Maple,¹ C. Callaghan,¹ J. Olsburgh,¹ F. Calder,¹ M. Drage,¹ N. Karydis,¹ I. Loukopoulos,¹ G. Koffman,¹ R. Hilton,¹ J. Pattison,¹ C. Farmer,³ S. Shah,² E. Spigler,¹ N. Mamode,¹ N. Kessaris.¹
Operating Room Extubation After Bilateral Lung Transplantation in Cystic Fibrosis Patients: A Single Center Experience

M.-L. Felten,¹ J.-D. Moyer,¹ J.-Y. Marandon,¹ J.-F. Dreyfus,² M. Fischler.¹
Operational Tolerance in Kidney Transplantation: Results of a Europe-Wide Survey

A. Massart,¹ A. Pallier,² O. Viklicky,^3,4 J. Pascual,^3,5 K. Budde,^3,6 S. Sorensen,^3,7 R. Oberbauer,^3,8 M. Klinger,^3,9 C. Dudley,^3,10 M. Sever,^3,11 G. Spasovski,^3,13 P. Guérif,² U. Maggiore,^3,12 M. Abramowicz,¹ M. Giral,² D. Abramowicz,¹⁴ S. Brouard.²
Opportunities in Tacrolimus Therapeutic Drug Monitoring

N. Jandovitz, J. Lee, S. Hammad, J. McKeen, S. Martin, D. Tsapepas.
Optimal Induction Therapy (IT) in Pancreas After Kidney Transplantation (PAK) According to Type of Kidney (kd) Donor and Patient Risk – A Registry Analysis

R. Gruessner,¹ A. Gruessner.²
Optimal Management of Distal Ureteric Stricture Following Renal Transplantation: A Systematic Review

J. Kwong, D. Schiefer, G. Anas, J. Archambault, P. Luke, A. Sener.
Organ Donation Attitudes of Hispanic College Students in the Rio Grande Valley: Analysis of Free Responses

Y. Tasnif,¹ S. Saladin,² A. Araya,¹ X. Wang.³
Organ Procurement Organization Level Changes in Liver Utilization After Share-35

E. Chow, A. Massie, X. Luo, A. Muzaale, D. Segev.
Orthotopic Transplantation of a Tissue Engineered Skin Graft in Athymic Mice

N. Nayakawde, P. Patil, K. Methe, M. Olausson.
Outbreak of Pandemic Influenza A (H1N1pdm) in a Kidney Transplant Unit – The Protective Effect of Vaccination

I. Helanterä,¹ V.-J. Anttila,² M. Lappalainen,³ M. Lempinen,¹ H. Isoniemi.¹
Outcome of Adult Kidney Transplant Candidates With Previous Malignancy: Analysis of 14-Year Waiting List Data in the United States

A. Santos, M. Casey, S. Rehman, X. Wen, K. Andreoni, K. Womer.
Outcome of Bortezomib/Plasmapheresis for the Sensitized Patient Awaiting Heart Transplant

J. Patel, N. Reinsmoen, M. Kittleson, D. Dilibero, F. Liou, D. Chang, M. Hamilton, L. Czer, F. Esmailian, J. Kobashigawa.
Outcome of Invasive Aspergillosis in Liver Transplant Recipients Under Current Antifungal Therapy

U. Herden, E. Grabhorn, B. Nashan, L. Fischer.
Outcome of Kidney Transplantation from Obese Living Donors: Histological Evaluation Using Zero-Time Biopsy Specimens

K. Omoto,¹ D. Toki,¹ M. Okumi,¹ T. Shimizu,¹ H. Ishida,¹ K. Honda,² J. Koike,³ K. Tanabe.¹
Outcome of Kidney Transplantation from Older Living Donors: Histological Evaluation Using Zero-Time Biopsy Specimens

K. Omoto,¹ D. Toki,¹ M. Okumi,¹ T. Shimizu,¹ H. Ishida,¹ K. Honda,² J. Koike,³ K. Tanabe.¹
Outcome of Kidney Transplantation Using Right Versus Three Left Renal Arteries After Retroperitoneoscopic Donor Nephrectomy: A Single-Center Experience of 764 Cases

K. Omoto, M. Okumi, T. Shimizu, D. Toki, H. Ishida, K. Tanabe.
Outcome of Renal Sparing Protocol in a Cross-Sectional Analysis After Heart Transplant

J. Kobashigawa, M. Kittleson, P. Patel, F. Liou, S. Siddiqui, D. Chang, B. Azarbal, D. Ramzy, L. Czer, J. Patel.
Outcomes After Listing for Kidney Transplantation in Adults Aged 70 Or Over

D. Kanigicherla, I. Zia, M. Morton, S. Skampardoni, M. Picton.
Outcomes After Right Kidney Living Donor Transplant Are Associated With Center Volume

R. Reed, P. MacLennan, B. Shelton, D. Sonnier, M. Hanaway, J. Goodman, C. Young, M. Deierhoi, J. Locke.
Outcomes Associated With Carbapenem-Resistant Klebsiella Pneumoniae (CRKP) in Solid Organ Transplant (SOT) Recipients

T. Bias,¹ A. Sharma,² G. Malat,³ D. Lee,² A. Doyle.²
Outcomes Between ABO-Incompatible Living Donor Liver Transplantation (LDLT) and ABO-Compatible LDLT: A Matched Study

J. Kim, S. Lee, W. Cho, J.-Y. Choi, G.-S. Choi, J. Park, C. Kwon, S. Kim, J.-W. Joh, S.-K. Lee.
Outcomes Following Endovascular Treatment of Hepatic Artery Stenosis Following Liver Transplantation

J. Seal,¹ H. Bohorquez,¹ L. Le,² W. Terral,² A. Cohen,¹ I. Carmody,¹ D. Bruce,¹ T. Reichman,¹ E. Ahmed,¹ W. Sternbergh,² G. Loss.¹
Outcomes Following Kidney Transplant With Low Level Positive Flow Cytometric Crossmatch

C. Schinstock, F. Cosio, M. Gandhi, L. Cornell, M. Stegall.
Outcomes in Kidney Transplant Recipients Over Age of 55 by Donor Source: LD, SCD, ECD

V. Kirchner, K. Gillingham, A. Matas, The Div of Tx and Tx Nephrology.
Outcomes in Liver Re-Transplant Recipients With MELD above 40: A Decade Long Experience

Z. Baghmanli,¹ C. Ortiz,² N. Koizumi,³ J. Ortiz.¹
Outcomes of ABO Incompatible Kidney Transplantation in Children

J. Stojanovic,¹ A. Adamusiak,² A. Waters,¹ D. Bockenhauer,¹ N. Kessaris,² C. Barton,³ H. Jones,³ J. Taylor,³ S. Marks,¹ N. Mamode.²
Outcomes of Eculizumab (ANTI-C5) Therapy for Treatment of Refractory Antiobdy-Mediated Rejection (ABMR) and Thrombotic Microangiopathy (TMA)

P. Wongsaroj,¹ J. Choi,¹ A. Vo,¹ J. Kahwaji,¹ A. Peng,¹ R. Villicana,¹ M. Haas,² S. Jordan.¹
Outcomes of Hepatitis C Virus (HCV) Treatment Following Liver Transplantation in the Era of Direct-Acting Antiviral Medications

S. Baggett,¹ D. Jones,¹ M. Shoreibah.²
Outcomes of Hispanic Kidney Transplant Recipients Under a Cyclosporine Versus Tacrolimus Based Immunosuppression Regimen

P. West-Thielke,¹ M. Campara,² A. Ladik,¹ E. Terranova,² E. Benedetti,¹ J. Thielke.²
Outcomes of HIV+ Liver Transplant Recipients Compared to HCV+ or HIV+/HCV+ Co-Infected Recipients: The “Real World” Experience

D. Sawinski,¹ G. David,² E. Blumberg,³ P. Abt,⁴ R. Bloom,¹ K. Forde.²
Outcomes of Kidney Transplant Recipients Minimally Immunosuppressed: A Cohort Study Analysis

A.-H. Querard,^1,2,3 F. Gillaizeau,^2,1 G. Couvrat-Desvergne,^1,2,3 J. Dantal,^1,4,5 P. Daguin,¹ S. Le Floch,¹ S. Castagnet,⁶ S. Brouard,^1,4 Y. Foucher,^2,1 M. Giral.^1,2,4,5
Outcomes of Kidney Transplantation from Hypertensive Living Donors

D.-A. Moutzouris, D. Ellis, K. Koutroutsos, R. Charif, J. Galliford, J. McDermott, D. Taube, M. Loucaidou.
Outcomes of Kidney Transplantation of ABO- and Crossmatch-Incompatible Recipient-Donor Pairs Entered in Kidney Paired Donation Program

D. Dadhania, M. Charlton, M. Aull, R. Friedlander, T. Muthukumar, J. Lee, M. Goris, D. Serur, S. Kapur, V. Sharma.
Outcomes of Live Kidney Donors Who Develop End Stage Renal Disease

A. Muzaale, A. Massie, L. Kucirka, D. Segev.
Outcomes of Living and Deceased Donor Liver Transplant Recipients According to the MELD Score

J. Lee, J. Lee, D. Joo, D. Han, M. Ju, J. Choi, S. Kim, M. Kim.
Outcomes of Patients With Hepatocellular Carcinoma Receiving a Donation After Cardiac Death Liver Graft

W. Goldkamp,¹ J. Vanatta,^2,3 S. Nair,^2,3 E. Wong,³ N. Dbouk.^2,3
Outcomes of Post-Kidney Transplant Leukemias

B. Rouphael, A. Kukla, K. Gillingham, H. Ibrahim, A. Matas, N. Issa.
Outcomes of Simultaneous Pancreas and Kidney Transplantation With a High Level of Preformed Antibodies

H. Sharma, A. El-Bakry, V. Venkat, S. Papachristos, R. Dhanda, D. Van Dellen, T. Campbell, T. Augustine, R. Pararajasingam, A. Tavakoli, B. Forgacs.
Outcomes of Solid Organ Transplantation in a National Private Health Plan: Comparison to SRTR Reports

F. Irwin,¹ C. Wu,¹ W. Bannister,² M. Schnitzler,¹ A. Bonagura.¹
Outcomes of Treatment of Late Antibody-Mediated Rejection in Primary Renal Transplant Recipients – A Single Center Experience

R. Prashar, A. Patel, K. Venkat.
Outpatient Management of Delayed Graft Function (DGF) Is Associated With Reduced Length of Stay and Acute Rejection

B. Muth,¹ B. Astor,¹ J. Turk,¹ M. Mohamed,¹ S. Parajuli,¹ D. Kaufman,² D. Mandelbrot,¹ A. Djamali.^1,2
Overexpression of 2B4 Inhibits the Expansion and Function of Donor-Reactive CD8+ T Cells in Selective Lymphoid Compartments

S. Laurie, D. Liu, M. Ford.
OX40 Gene: A Potential Target for the Care of Chronic T-Cell Mediated Rejection (TCMR)

F. Schena,¹ C. Curci,¹ F. Sallustio,¹ M. Trpevski,¹ G. De Palma,¹ M. Fiorentino,² M. Rossini,² M. Quaglia,³ E. Bozzola,³ S. Zanini,⁴ L. Furian,⁴ A. Toscano,⁵ E. Gallo,⁶ L. Gesualdo,² P. Stratta,³ P. Rigotti,⁴ F. Citterio,⁵ L. Biancone.⁶
Oxidative Stress During Organ Recovery Influences Transplant Vasculopathy Development

M. Maglione,¹ G. Riede,¹ B. Cardini,¹ D. Bernhard,² B. Messner,² K. Watschinger,³ C. Steger,⁴ G. Brandacher,⁵ J. Pratschke,¹ E. Werner,³ R. Oberhuber.¹

Jump to: View All • a b c d e f g h i j k l m n [o] p q r s t u v w x y z